Juniper Pharmaceuticals Inc (NASDAQ:JNP)

8.95
Delayed Data
As of May 25
 +0.10 / +1.13%
Today’s Change
4.05
Today|||52-Week Range
13.25
+84.54%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line3.4M-1.5M6.0M-2.1M
 
 
 
 
 
Depreciation2.0M1.9M1.9M2.3M
 
 
 
 
 
Total Other Cash Flow228.0K1.8M1.2M1.5M
 
 
 
 
 
Funds From Operations6.2M2.2M9.1M1.7M
 
 
 
 
 
Funds From/For Other Operating Expenses-777.0K3.1M-2.1M-465.0K
 
 
 
 
 
Net Cash Flow - Operating Activities6.9M-891.0K11.2M2.1M
 
 
 
 
 
 
InvestingCapital Expenditures-2.0M-1.7M-3.6M-2.8M
 
 
 
 
 
Net Cash Flow Investing-2.0M-1.7M-3.6M-2.8M
 
 
 
 
 
 
FinancingShort Term Borrowings------0.00--
Long Term Borrowings0.00----2.5M
 
 
Long Term Debt Reduction-245.0K-238.0K-226.0K-1.4M
 
 
 
 
 
Net Proceeds Stock Sale33.0K82.0K0.000.00
 
 
 
Common Preferred Redeemed-8.5M-22.0K0.000.00
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total-28.0K-28.0K-28.0K-14.0K
 
 
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-8.7M-206.0K-254.0K1.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-85.0K-56.0K-275.0K126.0K
 
 
 
 
 
 
Net Change In Cash-3.9M-2.8M7.4M326.0K